ST3GAL4 and Patent ductus arteriosus: To address the role of the α2,3-STs, ST3GAL3 and ST3GAL4 as potential new therapeutic targets of PDA, we have performed a comprehensive analysis of the effects of their knockdown on PDA cell function.